Tech Company Financing Transactions

Octave Bioscience Funding Round

Octave Bioscience closed a $32 million Series B funding round on 12/18/2020. Backers included Northpond Ventures, BVF Partners and Casdin Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Northpond Ventures (Lead Investor) (Michael Rubin)

BVF Partners

Casdin Capital

Deerfield Capital (Julian Harris)

Echo Health Ventures (Kurt Sheline)

Section 32 (Michael Pellini)

Proceeds Purpose
This financing will allow the company to complete development of its novel measurement and management products and services, further expand clinical data, initiate early commercial activities and begin to serve neurologists, MS patients and health plans.

Company Information

Company Status
Private & Independent
Healthcare Services
Mailing Address
1440 O'Brien Dr. B
Menlo Park, CA 94025
Email Address
Octave is developing a comprehensive, first-in-class Care Management Platform. Our team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. We're tackling neurodegenerative diseases -- starting with multiple sclerosis (MS).
Octave Bioscience LinkedIn Company Profile
Social Media
Octave Bioscience Company Twitter Account
Company News
Octave Bioscience News
Octave Bioscience on Facebook
Octave Bioscience on YouTube

Management Team

Email & Social
Chief Executive Officer
William Hagstrom
  William Hagstrom LinkedIn Profile  William Hagstrom Twitter Account  William Hagstrom News  William Hagstrom on Facebook
Chief Operating Officer
Melinda Thomas
  Melinda Thomas LinkedIn Profile  Melinda Thomas Twitter Account  Melinda Thomas News  Melinda Thomas on Facebook
Chief Technical Officer
Erwan Rivet
  Erwan Rivet LinkedIn Profile  Erwan Rivet Twitter Account  Erwan Rivet News  Erwan Rivet on Facebook
VP - Bus. Development
Maital Shemesh-Rasmussen
  Maital Shemesh-Rasmussen LinkedIn Profile  Maital Shemesh-Rasmussen Twitter Account  Maital Shemesh-Rasmussen News  Maital Shemesh-Rasmussen on Facebook



Browse more venture capital transactions:

Prev: 12/18/2020: Lyte venture capital transaction
Next: 12/18/2020: Vivace Therapeutics venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary